# K991238: Fci Crawford Probe Intubation Sets

- Pathway: 510(k) (Traditional)
- Applicant: Fci Ophthalmics, Inc.
- Decided: Jul 8, 1999 after 87 days
- Product code: OKS (Lacrimal Stents And Intubation Sets)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
5 later devices descend from it; 2 cite it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Most influential descendants
- K120886: Lacrifast (2012), 2 descendants of its own
- K121142: Crawford Biocanaliculus Intubation (2012), 2 descendants of its own
- K170247: Lacriflow CL (2017), 0 descendants of its own
- K161373: Nunchaku (2016), 0 descendants of its own
- K160710: Oasis Lacrimal Intubation Set (2016), 0 descendants of its own

## Indications for use
Epiphora in infants or adults, particularly in cases of canalicular pathologies (stenosis, obstruction or lacerations) dacryocysorhinostomy (conventional or .laser) imperforation of the nasolacrimal duct in an infant

Source page: https://510kreport.com/device/K991238
Methodology: https://510kreport.com/methodology